- Home
- ENGN vs REFI Comparison
ENGN vs REFI Comparison
Compare ENGN & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- REFI
- Stock Information
- Founded
- ENGN 1999
- REFI 2021
- Country
- ENGN Canada
- REFI United States
- Employees
- ENGN N/A
- REFI N/A
- Industry
- ENGN
- REFI Real Estate Investment Trusts
- Sector
- ENGN
- REFI Real Estate
- Exchange
- ENGN Nasdaq
- REFI Nasdaq
- Market Cap
- ENGN 297.7M
- REFI 314.2M
- IPO Year
- ENGN N/A
- REFI 2021
- Fundamental
- Price
- ENGN $5.15
- REFI $15.52
- Analyst Decision
- ENGN Buy
- REFI Strong Buy
- Analyst Count
- ENGN 9
- REFI 3
- Target Price
- ENGN $25.22
- REFI $20.00
- AVG Volume (30 Days)
- ENGN 44.3K
- REFI 185.3K
- Earning Date
- ENGN 03-10-2025
- REFI 03-12-2025
- Dividend Yield
- ENGN N/A
- REFI 16.60%
- EPS Growth
- ENGN N/A
- REFI N/A
- EPS
- ENGN N/A
- REFI 1.88
- Revenue
- ENGN N/A
- REFI $55,534,183.00
- Revenue This Year
- ENGN N/A
- REFI N/A
- Revenue Next Year
- ENGN N/A
- REFI N/A
- P/E Ratio
- ENGN N/A
- REFI $8.26
- Revenue Growth
- ENGN N/A
- REFI N/A
- 52 Week Low
- ENGN $4.42
- REFI $14.82
- 52 Week High
- ENGN $18.40
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- ENGN 35.95
- REFI 42.90
- Support Level
- ENGN $4.85
- REFI $15.08
- Resistance Level
- ENGN $5.60
- REFI $15.67
- Average True Range (ATR)
- ENGN 0.53
- REFI 0.29
- MACD
- ENGN -0.00
- REFI -0.08
- Stochastic Oscillator
- ENGN 25.69
- REFI 36.97
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.